# Ani Pharmaceuticals (ANIP): value investors who own it

0 value investors held Ani Pharmaceuticals in their Q3 2026 13F. See who bought, sold and how ownership has changed by quarter.

## 13F holders

| Manager | Portfolio | Value | Change | Quarters held |
| --- | --- | --- | --- | --- |
| Polen Capital Management | 0.0% | $0k | Sold out | 1 |

## Directors buying and selling (Form 4, last 12 months)

| Date | Who | Role | Bought or sold | Shares | Value |
| --- | --- | --- | --- | --- | --- |
| 2026-10-15 | Lalwani Nikhil | PRESIDENT & CEO | Sold | 5400 | $388k |
| 2026-10-13 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Sold | 500 | $37k |
| 2026-09-29 | CAREY STEPHEN P. | SVP & CFO | Sold | 2850 | $208k |
| 2026-09-15 | Lalwani Nikhil | PRESIDENT & CEO | Sold | 5400 | $383k |
| 2026-09-14 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Sold | 500 | $35k |
| 2026-09-11 | Thoma Jeanne | Director | Sold | 1000 | $72k |
| 2026-08-31 | CAREY STEPHEN P. | SVP & CFO | Sold | 2850 | $207k |
| 2026-08-25 | Lalwani Nikhil | PRESIDENT & CEO | Sold | 5400 | $401k |
| 2026-08-13 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Sold | 500 | $38k |
| 2026-08-10 | Gutwerg Ori | SVP, GENERICS | Sold | 3162 | $243k |
| 2026-07-29 | CAREY STEPHEN P. | SVP & CFO | Sold | 2850 | $232k |

Source: SEC filings, via moatshark (https://www.moatshark.com/s/anip). Values traded and returns are estimates. Not investment advice. Built 2026-10-21.